109 related articles for article (PubMed ID: 2060023)
1. Modulation of a human immunosuppressive lymphokine by monosaccharides.
Halpern MT; Schwartz SA
Cell Immunol; 1991 Aug; 136(1):29-40. PubMed ID: 2060023
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1982 Dec; 129(6):2511-8. PubMed ID: 6183335
[TBL] [Abstract][Full Text] [Related]
3. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
4. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of natural killer and interleukin 2-activated natural killer cell cytotoxicity by monosaccharides and lectins].
Imir T; Bankhurst AD
Mikrobiyol Bul; 1987 Oct; 21(4):245-50. PubMed ID: 3509759
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
8. Effector cell sensitivity to sugar moieties. III. Inhibition by monosaccharides of interleukin-2 enhanced natural killing against viral and nonviral tumor target cells.
Ades EW; Hinson A; Culwell M
J Clin Lab Immunol; 1986 Feb; 19(2):65-9. PubMed ID: 3485719
[TBL] [Abstract][Full Text] [Related]
9. Effector cell sensitivity to sugar moieties. II. Inhibition by monosaccharides of interferon enhanced human natural killing.
Ades EW; Hinson A
J Clin Lab Immunol; 1983 Aug; 11(4):173-6. PubMed ID: 6199501
[TBL] [Abstract][Full Text] [Related]
10. A human soluble suppressor factor affecting lymphocyte responses in vitro.
Shou L; Schwartz SA; Good RA; Peng R; Chen CL
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6096-100. PubMed ID: 6449702
[TBL] [Abstract][Full Text] [Related]
11. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
12. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition by monosaccharides of tumor cell cytotoxicity mediated by mouse macrophages, macrophage-like cell lines, and natural killer cells.
Brunda MJ; Wiltrout RH; Holden HT; Varesio L
Int J Cancer; 1983 Mar; 31(3):373-9. PubMed ID: 6826257
[TBL] [Abstract][Full Text] [Related]
14. Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
Rabinowich H; Sedlmayr P; Herberman RB; Whiteside TL
Cell Immunol; 1991 Jul; 135(2):454-70. PubMed ID: 1709827
[TBL] [Abstract][Full Text] [Related]
15. Purification of a suppressor lymphokine (SL) from a human T-cell line.
Abolhassani M; Muraki J; Chiao JW
Immunol Invest; 1989 Jul; 18(6):741-51. PubMed ID: 2767735
[TBL] [Abstract][Full Text] [Related]
16. Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay.
Nomori H; Saijo N; Fujita J; Hyoi M; Sasaki Y; Shimizu E; Kanzawa F; Inomata M; Hoshi A
Int J Cancer; 1985 Apr; 35(4):449-55. PubMed ID: 3872846
[TBL] [Abstract][Full Text] [Related]
17. Effector cell sensitivity to sugar moieties. I. Inhibition of human natural killer cell activity by monosaccharides.
Ades EW; Hinson A; Decker JM
Immunobiology; 1981; 160(2):248-58. PubMed ID: 7319544
[TBL] [Abstract][Full Text] [Related]
18. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of NK activity by oses: effect of interleukin 2 (author's transl)].
Vie H; Ythier A; Moreau JF; Peyrat MA; Soulillou JP
Ann Immunol (Paris); 1981; 132C(3):327-37. PubMed ID: 6174070
[TBL] [Abstract][Full Text] [Related]
20. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
Xiao J; Brahmi Z
Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
